|Bid||520.79 x 900|
|Ask||548.13 x 800|
|Day's range||513.26 - 521.52|
|52-week range||497.83 - 672.34|
|Beta (5Y monthly)||0.86|
|PE ratio (TTM)||27.72|
|Forward dividend & yield||1.20 (0.23%)|
|Ex-dividend date||14 Sept 2022|
|1y target est||N/A|
WALTHAM, Mass., September 07, 2022--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the Morgan Stanley 2022 Global Healthcare Conference on Monday, September 12, 2022, at 9:55 a.m. (EDT).
HILLSBORO, Ore., August 03, 2022--Thermo Fisher Scientific Inc., the world leader in serving science, and Structura Biotechnology Inc., a leading provider of cryo-EM data analysis software, today announced a collaboration to make available a new single particle analysis software solution, a version of Structura’s CryoSPARC Live, that is designed to integrate with Thermo Fisher’s Smart EPU software and cryo-transmission electron microscope (cryo-TEM) technology. The new solution, Embedded CryoSPA
WALTHAM, Mass., July 28, 2022--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the second quarter ended July 2, 2022.